Gray Nancy Ryan bought LGND
June 5, 2026 · Form 4 insider transaction
Gray Nancy Ryan bought 836 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
836
Price
$0.00
Total value
N/A
InsiderGray Nancy Ryan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 9, 2026
Shares owned after8,930
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.